Collaboration aims to quickly enable ulixacaltamide to be delivered via active transdermal route Potential to expand the addressable ...
PharmaTher Enters Into Process Development Agreement With LTS LOHMANN for Ketamine Microneedle Patch
TORONTO and ANDERNACH, Germany, Dec. 20, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (“PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the development and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results